Similarly, also miR-223-3p dysregulation seems to be involved in AD pathogenesis by modulating many other targets involved in differentiation/proliferation (i.e., NFI-A;/EBPbeta, Mef2c) and NF-kB pathways (i.e., STAT3, IKK). This evidence concerns the gene MEF2C and Alzheimer disease.